References
- BodmeierRChenHGPaeratakulOA novel approach to the oral delivery of micro- or nanoparticlesPharm Res1989654134172748533
- De JaeghereFAllémannEKubelFOral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional stateJ Control Release200068229129810925137
- BourzacKNanotechnology: carrying drugsNature20124917425S58S6023320289
- PathakKRaghuvanshiSOral bioavailability: issues and solutions via nanoformulationsClin Pharmacokinet201554432535725666353
- LiFQYanCBiJA novel spray-dried nanoparticles-in-microparticles system for formulating scopolamine hydrobromide into orally disintegrating tabletsInt J Nanomedicine2011689790421720502
- PintoJFMüllerRHPellets as carriers of solid lipid nanoparticles (SLN) for oral administration of drugsPharmazie199954506509
- DasSChaudhuryARecent advances in lipid nanoparticle formulations with solid matrix for oral drug deliveryAAPS PharmSciTech2011121627621174180
- Bernkop-SchnürchANanocarrier systems for oral drug delivery: do we really need them?Eur J Pharm Sci201349227227723537503
- MehnertWSolid lipid nanoparticles: production, characterization and applicationsAdv Drug Deliv Rev2001472–316519611311991
- KhanAWKottaSAnsariSHSharmaRKAliJPotentials and challenges in self-nanoemulsifying drug delivery systemsExpert Opin Drug Deliv20129101305131722954323
- BalakrishnanPLeeBJOhDHEnhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery system (SEDDS)Eur J Pharm Biopharm200972353954519298857
- OhshimaHMiyagishimaAKuritaTFreeze-dried nifedipine-lipid nanoparticles with long-term nano-dispersion stability after reconstitutionInt J Pharm20093771–218018419446623
- TahaEIAl-SuwayehSAAnwerMKPreparation, in vitro and in vivo evaluation of solid-state self-nanoemulsifying drug delivery system (SNEDDS) of vitamin A acetateJ Drug Target200917646847319480612
- MahmoudEABendasERMohamedMIPreparation and evaluation of self-nanoemulsifying tablets of carvedilolAAPS PharmSciTech200910118319219238556
- FriedrichRBFontanaMCBastosMOPohlmannARGuterresSSBeckRCDrying polymeric drug-loaded nanocapsules: the wet granulation process as a promising approachJ Nanosci Nanotechnol201010161662120352901
- AntonelliGTurrizianiOAntiviral therapy: old and current issuesInt J Antimicrob Agents20124029510222727532
- DurandCMFlexnerCHIV cure: knocking on the doorClin Pharmacol Ther201393538238423598454
- FarmerPLéandreFMukherjeeJGuptaRTarterLKimJYCommunity-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy)Bull World Health Organ200179121145115111799447
- DugganJMAkpanudoBShuklaVGuttersonGEitniearLSahloffEGAlternative antiretroviral therapy formulations for patients unable to swallow solid oral dosage formsAm J Health Syst Pharm201572181555156526346211
- BeckerSAtazanavir: improving the HIV protease inhibitor classExpert Rev Anti Infect Ther20031340341315482137
- ChokephaibulkitKNuntarukchaikulMPhongsamartWOnce- versus twice-daily lopinavir/ritonavir tablets in virologically suppressed, HIV-infected, treatment-experienced children: comparative pharmacokinetics and virological outcome after switching to once-daily lopinavir/ritonavirJ Antimicrob Chemother201267122927293122923483
- ColomboSBuclinTCavassiniMPopulation pharmacokinetics of atazanavir in patients with human immunodeficiency virus infectionAntimicrob Agents Chemother200650113801380816940065
- Toronto HIV ClinicOral antiretroviral administration: information on crushing and liquid drug formulations2014 Available from: http://www.hivclinic.ca/main/drugs_extra_files/Crushing%20and%20Liquid%20ARV%20Formulations.pdfAccessed February 2, 2016
- World Health OrganizationItem 4: Updated list of missing drug formulations for HIV treatment2011 Available from: http://www.who.int/selection_medicines/committees/expert/18/policy/policy4/enAccessed February 2, 2016
- DongXMattinglyCATsengMChoMAdamsVRMumperRJDevelopment of new lipid-based paclitaxel nanoparticles using sequential simplex optimizationEur J Pharm Biopharm200972191719111929
- StipplerEKoppSDressmanJComparison of US Pharmacopeia simulated intestinal fluid TS (without pancreatin) and phosphate standard buffer pH 6.8, TS of the International Pharmacopoeia with respect to their use in in vitro dissolution testingDissolut Technol20045610
- DamaramaduguRInamaduguJKannetiRPolaganiSPonneriVSimultaneous determination of ritonavir and lopinavir in human plasma after protein precipitation and LC-MS-MSChromatographia2010719–10815824